Metastasis suppressor KAI1/CD82 attenuates the matrix adhesion of human prostate cancer cells by suppressing fibronectin expression and β 1 integrin activation

Cellular Physiology and Biochemistry

Volumn 27, Issue 5, 2011, Pages 575-586

  Lee, Hyun Ah ^a   Park, Iha ^a   Byun, Hee Jung ^a   Jeoung, Dooil ^a   Kim, Young Myeong ^a   Lee, Hansoo ^a  

^a Kangwon National University   (South Korea)

Author keywords

Adhesion; CD82; Extracellular matrix; Fibronectin; Integrin; KAI1; Metastasis

Indexed keywords

BETA1 INTEGRIN; CD82 ANTIGEN; COMPLEMENTARY DNA; FIBRONECTIN;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL; CELL ADHESION; CELL MOTILITY; CELL SURFACE; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN SECRETION;

EID: 79959444311     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000329979     Document Type: Article

References (52)

1. Dong JT, Lamb PW, Rinker-Schaeffer CW, Vukanovic J, Ichikawa T, Isaacs JT, Barrett JC: Kai1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 1995;268:884-886.
2. Yang X, Wei LL, Tang C, Slack R, Mueller S, Lippman ME: Overexpression of kai1 suppresses in vitro invasiveness and in vivo metastasis in breast cancer cells. Cancer Res 2001;61:5284-5288. (Pubitemid 32681565)
3. Si SH, Yang JM, Peng ZH, Luo YH, Zhou P: Effects of kai1 gene on growth and invasion of human hepatocellular carcinoma mhcc97-h cells. World J Gastroenterol 2004;10:2019-2023. (Pubitemid 39106950)
4. Takeda T, Hattori N, Tokuhara T, Nishimura Y, Yokoyama M, Miyake M: Adenoviral transduction of mrp-1/cd9 and kai1/cd82 inhibits lymph node metastasis in orthotopic lung cancer model. Cancer Res 2007;67:1744-1749. (Pubitemid 46383401)
5. Yang JM, Peng ZH, Si SH, Liu WW, Luo YH, Ye ZY: Kai1 gene suppresses invasion and metastasis of hepatocellular carcinoma mhcc97-h cells in vitro and in animal models. Liver Int 2008;28:132-139.
6. Bouras T, Frauman AG: Expression of the prostate cancer metastasis suppressor gene kai1 in primary prostate cancers: A biphasic relationship with tumour grade. J Pathol 1999;188:382-388. (Pubitemid 29327436)
7. Tricoli JV, Schoenfeldt M, Conley BA: Detection of prostate cancer and predicting progression: Current and future diagnostic markers. Clin Cancer Res 2004;10:3943-3953. (Pubitemid 38812467)
8. Ueda T, Ichikawa T, Tamaru J, Mikata A, Akakura K, Akimoto S, Imai T, Yoshie O, Shiraishi T, Yatani R, Ito H, Shimazaki J: Expression of the kai1 protein in benign prostatic hyperplasia and prostate cancer. Am J Pathol 1996;149:1435-1440. (Pubitemid 26363949)
9. Hinoda Y, Adachi Y, Takaoka A, Mitsuuchi H, Satoh Y, Itoh F, Kondoh Y, Imai K: Decreased expression of the metastasis suppressor gene kai1 in gastric cancer. Cancer Lett 1998;129:229-234. (Pubitemid 28386606)
10. Lombardi DP, Geradts J, Foley JF, Chiao C, Lamb PW, Barrett JC: Loss of kai1 expression in the progression of colorectal cancer. Cancer Res 1999;59:5724-5731.
11. Takaoka A, Hinoda Y, Satoh S, Adachi Y, Itoh F, Adachi M, Imai K: Suppression of invasive properties of colon cancer cells by a metastasis suppressor kai1 gene. Oncogene 1998;16:1443-1453. (Pubitemid 28151851)
12. Liu FS, Chen JT, Dong JT, Hsieh YT, Lin AJ, Ho ES, Hung MJ, Lu CH: Kai1 metastasis suppressor gene is frequently down-regulated in cervical carcinoma. Am J Pathol 2001;159:1629-1634. (Pubitemid 33062505)
13. Schindl M, Birner P, Bachtiary B, Breitenecker G, Selzer E, Oberhuber G: Kai1 metastasis suppressor protein in cervical cancer. Am J Pathol 2002;160:1542-1543. (Pubitemid 34411658)
14. Yang X, Wei L, Tang C, Slack R, Montgomery E, Lippman M: Kai1 protein is down-regulated during the progression of human breast cancer. Clin Cancer Res 2000;6:3424-3429.
15. Yang X, Welch DR, Phillips KK, Weissman BE, Wei LL: Kai1, a putative marker for metastatic potential in human breast cancer. Cancer Lett 1997;119:149-155. (Pubitemid 27478097)
16. Geradts J, Maynard R, Birrer MJ, Hendricks D, Abbondanzo SL, Fong KM, Barrett JC, Lombardi DP: Frequent loss of kai1 expression in squamous and lymphoid neoplasms. An immunohistochemical study of archival tissues. Am J Pathol 1999;154:1665-1671. (Pubitemid 29262848)
17. Jackson P, Kingsley EA, Russell PJ: Inverse correlation between kai1 mrna levels and invasive behaviour in bladder cancer cell lines. Cancer Lett 2000;156:9-17. (Pubitemid 30326762)
18. Ow K, Delprado W, Fisher R, Barrett J, Yu Y, Jackson P, Russell PJ: Relationship between expression of the kai1 metastasis suppressor and other markers of advanced bladder cancer. J Pathol 2000;191:39-47. (Pubitemid 30235647)
19. Yu Y, Yang JL, Markovic B, Jackson P, Yardley G, Barrett J, Russell PJ: Loss of kai1 messenger rna expression in both high-grade and invasive human bladder cancers. Clin Cancer Res 1997;3:1045-1049. (Pubitemid 27319749)
20. Adachi M, Taki T, Ieki Y, Huang CL, Higashiyama M, Miyake M: Correlation of kai1/cd82 gene expression with good prognosis in patients with non-small cell lung cancer. Cancer Res 1996;56:1751-1755. (Pubitemid 26118208)
21. Friess H, Guo XZ, Tempia-Caliera AA, Fukuda A, Martignoni ME, Zimmermann A, Korc M, Buchler MW: Differential expression of metastasis-associated genes in papilla of vater and pancreatic cancer correlates with disease stage. J Clin Oncol 2001;19:2422-2432. (Pubitemid 32391213)
22. Guo XZ, Friess H, Di Mola FF, Heinicke JM, Abou-Shady M, Graber HU, Baer HU, Zimmermann A, Korc M, Buchler MW: Kai1, a new metastasis suppressor gene, is reduced in metastatic hepatocellular carcinoma. Hepatology 1998;28:1481-1488. (Pubitemid 28549116)
23. Sun HC, Tang ZY, Zhou G, Li XM: Kai1 gene expression in hepatocellular carcinoma and its relationship with intrahepatic metastases. J Exp Clin Cancer Res 1998;17:307-311. (Pubitemid 29090374)
24. Chen Z, Mustafa T, Trojanowicz B, Brauckhoff M, Gimm O, Schmutzler C, Kohrle J, Holzhausen HJ, Kehlen A, Klonisch T, Finke R, Dralle H, Hoang-Vu C: Cd82, and cd63 in thyroid cancer. Int J Mol Med 2004;14:517-527.
25. Maecker HT, Todd SC, Levy S: The tetraspanin superfamily: Molecular facilitators. FASEB J 1997;11:428-442. (Pubitemid 27259984)
26. Stipp CS, Kolesnikova TV, Hemler ME: Functional domains in tetraspanin proteins. Trends Biochem Sci 2003;28:106-112. (Pubitemid 36165140)
27. Liu WM, Zhang XA: Kai1/cd82, a tumor metastasis suppressor. Cancer Lett 2006;240:183-194. (Pubitemid 44093816)
28. Miranti CK: Controlling cell surface dynamics and signaling: How cd82/kai1 suppresses metastasis. Cell Signal 2009;21:196-211.
29. Luo BH, Carman CV, Springer TA: Structural basis of integrin regulation and signaling. Annu Rev Immunol 2007;25:619-647. (Pubitemid 46697919)
30. Arnaout MA, Goodman SL, Xiong JP: Structure and mechanics of integrinbased cell adhesion. Curr Opin Cell Biol 2007;19:495-507. (Pubitemid 350019555)
31. Jin H, Varner J: Integrins: Roles in cancer development and as treatment targets. Br J Cancer 2004;90:561-565. (Pubitemid 38297190)
32. Ruseva Z, Geiger PX, Hutzler P, Kotzsch M, Luber B, Schmitt M, Gross E, Reuning U: Tumor suppressor kai1 affects integrin alphavbeta3-mediated ovarian cancer cell adhesion, motility, and proliferation. Exp Cell Res 2009;315:1759-1771.
33. Sridhar SC, Miranti CK: Tetraspanin kai1/cd82 suppresses invasion by inhibiting integrin-dependent crosstalk with c-met receptor and src kinases. Oncogene 2006;25:2367-2378.
34. He B, Liu L, Cook GA, Grgurevich S, Jennings LK, Zhang XA: Tetraspanin cd82 attenuates cellular morphogenesis through down-regulating integrin alpha6-mediated cell adhesion. J Biol Chem 2005;280:3346-3354. (Pubitemid 40223797)
35. Jee BK, Lee JY, Lim Y, Lee KH, Jo YH: Effect of kai1/cd82 on the beta1 integrin maturation in highly migratory carcinoma cells. Biochem Biophys Res Commun 2007;359:703-708. (Pubitemid 46899009)
36. Lim S, Lee HY, Lee H: Inhibition of colonization and cell-matrix adhesion after nm23-h1 transfection of human prostate carcinoma cells. Cancer Lett 1998;133:143-149. (Pubitemid 29069038)
37. Lee JH, Seo YW, Park SR, Kim YJ, Kim KK: Expression of a splice variant of kai1, a tumor metastasis suppressor gene, influences tumor invasion and progression. Cancer Res 2003;63:7247-7255. (Pubitemid 37413464)
38. Berditchevski F: Complexes of tetraspanins with integrins: More than meets the eye. J Cell Sci 2001;114:4143-4151. (Pubitemid 33138652)
39. Berditchevski F, Odintsova E: Characterization of integrin-tetraspanin adhesion complexes: Role of tetraspanins in integrin signaling. J Cell Biol 1999;146:477-492. (Pubitemid 29369782)
40. Mannion BA, Berditchevski F, Kraeft SK, Chen LB, Hemler ME: Transmembrane-.4. superfamily proteins cd81 (tapa-1), cd82, cd63, and cd53 specifically associated with integrin alpha 4 beta 1 (cd49d/cd29). J Immunol 1996;157:2039-2047.
41. Ono M, Handa K, Withers DA, Hakomori S: Glycosylation effect on membrane domain (gem) involved in cell adhesion and motility: A preliminary note on functional alpha3, alpha5-cd82 glycosylation complex in ldld 14 cells. Biochem Biophys Res Commun 2000;279:744-750. (Pubitemid 32042851)
42. Berditchevski F, Odintsova E: Tetraspanins as regulators of protein trafficking. Traffic 2007;8:89-96. (Pubitemid 46099996)
43. Akiyama SK, Yamada SS, Yamada KM: Analysis of the role of glycosylation of the human fibronectin receptor. J Biol Chem 1989;264:18011-18018. (Pubitemid 19279270)
44. Lydolph MC, Morgan-Fisher M, Hoye AM, Couchman JR, Wewer UM, Yoneda A: Alpha9beta1 integrin in melanoma cells can signal different adhesion states for migration and anchorage. Exp Cell Res 2009;315:3312-3324.
45. Lau LM, Wee JL, Wright MD, Moseley GW, Hogarth PM, Ashman LK, Jackson DE: The tetraspanin superfamily member cd151 regulates outside-in integrin alphaiibbeta3 signaling and platelet function. Blood 2004;104:2368-2375. (Pubitemid 39331835)
46. Serru V, Le Naour F, Billard M, Azorsa DO, Lanza F, Boucheix C, Rubinstein E: Selective tetraspan-integrin complexes (cd81/alpha4beta1, cd151/alpha3beta1, cd151/alpha6beta1) under conditions disrupting tetraspan interactions. Biochem J 1999;340:103-111. (Pubitemid 29251096)
47. Sincock PM, Fitter S, Parton RG, Berndt MC, Gamble JR, Ashman LK: Peta-3/cd151, a member of the transmembrane .4. superfamily, is localised to the plasma membrane and endocytic system of endothelial cells, associates with multiple integrins and modulates cell function. J Cell Sci 1999;112:833-844. (Pubitemid 29179316)
48. Fitter S, Sincock PM, Jolliffe CN, Ashman LK: Transmembrane 4 superfamily protein cd151 (peta-3) associates with beta 1 and alpha iib beta 3 integrins in haemopoietic cell lines and modulates cell-cell adhesion. Biochem J 1999;338:61-70. (Pubitemid 29097286)
49. Nishiuchi R, Sanzen N, Nada S, Sumida Y, Wada Y, Okada M, Takagi J, Hasegawa H, Sekiguchi K: Potentiation of the ligand-binding activity of integrin alpha3beta1 via association with tetraspanin cd151. Proc Natl Acad Sci USA 2005;102:1939-1944. (Pubitemid 40261991)
50. Liu C, Yao J, Mercola D, Adamson E: The transcription factor egr-1 directly transactivates the fibronectin gene and enhances attachment of human glioblastoma cell line u251. J Biol Chem 2000;275:20315-20323. (Pubitemid 30457606)
51. Baron V, Adamson ED, Calogero A, Ragona G, Mercola D: The transcription factor egr1 is a direct regulator of multiple tumor suppressors including tgfbeta1, pten, p53, and fibronectin. Cancer Gene Ther 2006;13:115-124. (Pubitemid 43113412)
52. Cabodi S, Morello V, Masi A, Cicchi R, Broggio C, Distefano P, Brunelli E, Silengo L, Pavone F, Arcangeli A, Turco E, Tarone G, Moro L, Defilippi P: Convergence of integrins and egf receptor signaling via pi3k/akt/foxo pathway in early gene egr-1 expression. J Cell Physiol 2009;218:294-303.